Calcium intravenous infsuion
PreclinicalSmall molecule
Calcium intravenous infsuion is one of 37 small molecule programs targeting Periodontitis. It is currently in Preclinical.
2
Indications
9
Total Trials
7
Active Trials
36
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
138 competitors in Periodontitis
#DrugCompanyPhaseTrials
1Peridex
DDexcel Pharma Technologies Ltd.
Phase 3
Acanya
PfizerPhase 3
Curcumin
Merck & Co.Phase 3
Calcium Hydroxide
MMansoura University
Phase 3
Atorvastatin Calcium
Merck & Co.Phase 2
Glutamine
SanofiPhase 2
Minocycline Hcl
OOraPharma
Phase 3
Boswellia
MMansoura University
Phase 3
Metapex
AAga Khan University
Phase 3
Leddermix
MMansoura University
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Periodontitis2 trials
Post Operative Pain2 trials
Inflammatory Cytokines1 trial
Efficacy of 810 nm Diode Laser Disinfection on Inflammatory Cytokines and Postoperative Pain After Endodontic Retreatment
Recruiting·—·N/A·NCT07141459·52 enrolled
Endodontic Treatment1 trial
2 more indications
Intracanal Dressing1 trial
Effect of Bio-C Temp Versus Calcium Ydroxide as Intracanal Dressings on Postoperative Pain Intensity and Periapical MMP-9 Level in Patients With Necrotic Pulp
Not yet recruiting·—·Phase 1·NCT07101029·30 enrolled
Ovarian Hyperstimulation Syndrome1 trial
Ovarian Hyperstimulation Syndrome Using Calcium Infusion
Unknown status·—·N/A·NCT05198128·200 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMansoura University